MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced the appointment of Susan G. Kim as Chief Financial Officer, effective as of September 28, 2020. “I am delighted that Susan is joining the company at a time where we have […]
Whole Transcriptome Atlas Service Based in NanoString’s Seattle Labs Premier Access Sites to Offer the Cancer Transcriptome Atlas Service from Labs Across the Globe SEATTLE–(BUSINESS WIRE)– NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the establishment of the GeoMx Premier Access Sites, a global service network […]
Strengthens Bruker in Targeted Multi-Omics and High-Plex Biomarker Imaging Adds Innovative ChipCytometry Tools for Multi-Dimensional Immune Profiling BILLERICA, Mass.– Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Canopy Biosciences, LLC, a leader in high multiplex biomarker imaging for immunology, immuno-oncology and cell therapy. This acquisition enhances Bruker’s offering in targeted multi-omics and fluorescence-based imaging techniques. […]
CORALVILLE, Iowa – Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, announced that Novogene, a world leader in Next Generation Sequencing (NGS) services, has joined the IDT Align℠ Preferred Sequencing Provider Program. The combination of Novogene’s leading bioinformatics and analysis services with IDT’s high quality and flexible products offers researchers an invaluable resource for their genomics […]
Collaboration will fast track the development and scale-up of Evonetix’s desktop DNA writer towards commercialisation and first product Technology will help facilitate the rapidly growing multibillion-dollar synthetic biology industry CAMBRIDGE, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced a collaboration with leading, […]
London, UK — PCR Biosystems has today launched RiboShield™ RNase Inhibitor. Already an important component of several PCR Biosystems kits, this robust and reliable RNase inhibitor is, for the first time, available as a standalone product. RiboShield™ RNase Inhibitor is a recombinant protein that blocks the activity of a wide range of ribonucleases to […]
New laboratory tool promises analytical power in a small footprint CAMBRIDGE, Mass. — miniPCR bio, a manufacturer of scientific tools for educators and researchers, today announced the launch of the GELATO™, an integrated DNA analysis system. GELATO™ combines gel electrophoresis with transillumination technology, allowing for simultaneous nucleic acid separation and visualization in a single, compact system. GELATO™ […]
Applied Biosystems RapidHIT ID System plays key role in arrestee testing and investigative lead generation SOUTH SAN FRANCISCO, Calif. — The U.S. Federal Bureau of Investigation (FBI) has approved Thermo Fisher Scientific’s Applied Biosystems RapidHIT ID System for use by accredited forensic DNA laboratories to process DNA reference samples and search resulting profiles against the U.S. […]
FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer
CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO CARLSBAD, Calif. — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to identify RET fusion-positive, metastatic non-small cell lung cancer (NSCLC) patients who are candidates for GAVRETO™ (pralsetinib), […]
Leading institute will implement our technology and training with goal of epidemic prevention When the coronavirus outbreak hit at the end of 2019, the P3 Biosafety Laboratory research team at Shanghai Public Health Clinical Center (SPHCC) deployed the Illumina MiniSeq™ for the deep transcriptome sequencing of patients’ samples. SPHCC also was among the first to […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
